An ICG/iopamidol mixture was prepared as a VATS marker solution by diluting ICG (2.5 mg/mL, 10 mL; Daiichi-Sankyo, Tokyo, Japan) 100-fold with iopamidol (Iopamiron 370; Bayer, Leverkusen, Germany). A 1-mL syringe was filled with the ICG/iopamidol mixture and connected to either a 23-gauge CT-guided percutaneous needle or a 21-gauge bronchoscopic biopsy needle (NA-1C-1; Olympus America). The needle lumen was filled with the marking solution prior to the marking procedure.

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.